Bioavailability Study of EVEGYN 600 mg/1000 mg/100 mg Vaginal Ovule

NCT05361369 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioavailability

Interventions

DRUG: EVEGYN 600 mg/1000 mg/100 mg Vaginal Ovule

Sponsor

Exeltis Turkey

Collaborators

[object Object]